USA > JAPAN based Otsuka Pharmaceutical is set to acquire USA based Visterra for approximately $430 million

otsuka logo In an all cash transaction, Japan based Otsuka Pharmaceutical is set to acquire USA based Visterra Inc. for approximately $430 million. The transaction has been approved by boards of directors of both companies and the deal is subject to customary closing conditions, including expiration or termination of the waiting period under U.S. antitrust laws and is expected to close in More …